Common Names
Geographic Range: India (throughout), Sri Lanka, Nepal, Southeast Asia, eastern Africa, northern Australia.
Known Contraindications
1
Compounds
4
Traditions
4
Treatments
1
Conditions
CYP Interaction Profile
| Enzyme | Interaction |
|---|---|
| metabolism | Hydrolyzed to sarsasapogenin aglycone by gut flora. Hepatic Phase II conjugation. |
| interactions | Caution with estrogen-sensitive conditions (breast cancer, endometriosis). May potentiate diuretics. Additive with galactagogues. |